New Data for BioMarin’s VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting
This weekend, BioMarin, the Diamond Sponsor for the 6th Annual Achondroplasia & Skeletal Dysplasia Research Conference, presented new data at the Pediatric Endocrine Society Meeting in Chicago. BioMarin announced positive…